Results from the first HIV vaccine trial in infants in Africa
Feasibility
and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants
in uganda: Results from the first HIV vaccine trial in infants in Africa. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.